Cargando…
Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
INTRODUCTION: This work investigated the relationship between cerebrovascular disease (CVD) markers and Alzheimer's disease (AD) biomarkers of amyloid beta deposition, and neurofibrillary tau tangles in subjects spanning the AD clinical spectrum. METHODS: A total of 136 subjects participated in...
Autores principales: | Rivera‐Rivera, Leonardo A., Eisenmenger, Laura, Cody, Karly A., Reher, Thomas, Betthauser, Tobey, Cadman, Robert V., Rowley, Howard A., Carlsson, Cynthia M., Chin, Nathaniel A., Johnson, Sterling C., Johnson, Kevin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719432/ https://www.ncbi.nlm.nih.gov/pubmed/35005194 http://dx.doi.org/10.1002/dad2.12253 |
Ejemplares similares
-
Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020) -
Trajectory of clinical symptoms in relation to amyloid chronicity
por: Birdsill, Alex C., et al.
Publicado: (2022) -
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
por: Lao, Patrick J., et al.
Publicado: (2017) -
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
por: Betthauser, Tobey J, et al.
Publicado: (2020) -
Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention
por: Doherty, Benjamin M., et al.
Publicado: (2015)